比索洛尔对慢性心力衰竭治疗的临床效果评价

Evaluation on Clinical Effect of Bisoprolol in Treatment of Chronic Heart Failure

目的分析比索洛尔对慢性心力衰竭治疗的临床效果。方法方便选取2016年3月—2017年5月该院收治的68例慢性心力衰竭患者作为研究资料,回顾性分析该68例患者的病历资料,按照治疗方式的不同将将其分成两组,接受常规治疗的34例患者为参照组,接受比索洛尔治疗的34例患者为研究组,对比两组患者的临床疗效。结果所有患者经治疗后都有不同程度的改善,其中研究组患者的治疗总有效率(97.1%)同参照组治疗总有效率(76.5%)进行比对差异有统计学意义(P<0.05)。全体患者经治疗后临床指标均有不同程度的改善,但研究组同参照组比对明显较优,另外,从不良反应的发生率来看,研究组不良反应发生率仅为5.8%,与参照组的35.2%对比差异有统计学意义(P<0.05)。结论对慢性心力衰竭患者予以比索洛尔,效果理想,患者的心功能可以有效改善,同时具有较高的安全性,可在临床上进一步普及和实践。

Objective To analyze the clinical effect of bisoprolol in treatment of chronic heart failure. Methods 68 cases of patients with chronic heart failure admitted and treated in our hospital from March 2016 to May 2017 were convenient selected,and the medical records data of the 68 cases were reviewed, and the patients were divided into two groups according different methods, with 34 cases in each, the control group used the routine treatment, while the research group were treated with bisoprolol, and the clinical curative effect was compared between the two groups. Results All patients had different degrees of improvement, and the difference in the total treatment effective rate between the research group and the control group was obvious（97.1% vs 76.5%）（P〈0.05）, after treatment, the clinical indicators were improved to a certain degree, but the clinical indicators in the research group were obviously better than those in the control group, besides, the incidence rate of adverse reactions in the research group and in the control group was respectively 5.8% and 35.2%, and the difference was statistically significant（P〈0.05）. Conclusion The effect of bisoprolol in treatment of chronic heart failure is ideal, which can effectively improve the cardiac function of patients with high safety, and it can be further promoted and applied.